Cymat Technologies Valuation
| CYMHF Stock | USD 0.16 0.02 14.29% |
Cymat Technologies seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cymat Technologies from analyzing the firm fundamentals such as Current Valuation of 14.54 M, profit margin of (1.47) %, and Return On Equity of -2.41 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Cymat Technologies' price fluctuation is out of control at this time. Calculation of the real value of Cymat Technologies is based on 3 months time horizon. Increasing Cymat Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cymat otc stock is determined by what a typical buyer is willing to pay for full or partial control of Cymat Technologies. Since Cymat Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cymat OTC Stock. However, Cymat Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.16 | Real 0.12 | Hype 0.16 | Naive 0.16 |
The real value of Cymat OTC Stock, also known as its intrinsic value, is the underlying worth of Cymat Technologies OTC Stock, which is reflected in its stock price. It is based on Cymat Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cymat Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cymat Technologies helps investors to forecast how Cymat otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cymat Technologies more accurately as focusing exclusively on Cymat Technologies' fundamentals will not take into account other important factors: Cymat Technologies Total Value Analysis
Cymat Technologies is currently forecasted to have takeover price of 14.54 M with market capitalization of 19.99 M, debt of 123.93 K, and cash on hands of 2.21 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cymat Technologies fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.54 M | 19.99 M | 123.93 K | 2.21 M |
Cymat Technologies Investor Information
The company recorded a loss per share of 0.06. Cymat Technologies had not issued any dividends in recent years. The entity had 1:10 split on the 25th of June 2014. Based on the key indicators related to Cymat Technologies' liquidity, profitability, solvency, and operating efficiency, Cymat Technologies is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Cymat Technologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cymat Technologies has an asset utilization ratio of 50.62 percent. This implies that the OTC Stock is making $0.51 for each dollar of assets. An increasing asset utilization means that Cymat Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Cymat Technologies Ownership Allocation
Cymat Technologies holds a total of 59.09 Million outstanding shares. Cymat Technologies shows 6.28 percent of its outstanding shares held by insiders and 2.38 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cymat Technologies Profitability Analysis
The company reported the revenue of 3.12 M. Net Loss for the year was (4.75 M) with profit before overhead, payroll, taxes, and interest of 795.48 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cymat Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cymat Technologies and how it compares across the competition.
About Cymat Technologies Valuation
The otc valuation mechanism determines Cymat Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of Cymat Technologies. We calculate exposure to Cymat Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cymat Technologies's related companies.Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States.
8 Steps to conduct Cymat Technologies' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Cymat Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cymat Technologies' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cymat Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cymat Technologies' revenue streams: Identify Cymat Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cymat Technologies' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cymat Technologies' growth potential: Evaluate Cymat Technologies' management, business model, and growth potential.
- Determine Cymat Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cymat Technologies' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cymat Technologies Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cymat Technologies does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 55.5 M | |
| Retained Earnings | -87 M |
Complementary Tools for Cymat OTC Stock analysis
When running Cymat Technologies' price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |